AAAAAA
Results: 26-33/33
Authors:
Kerner, T
Deja, M
Ahlers, O
Loffel, J
Hildebrandt, B
Wust, P
Gerlach, H
Riess, H
Citation: T. Kerner et al., Whole body hyperthermia: a secure procedure for patients with various malignancies?, INTEN CAR M, 25(9), 1999, pp. 959-965
Authors:
Horstkamp, BS
Kiess, H
Kramer, J
Riess, H
Henrich, W
Dudenhausen, JW
Citation: Bs. Horstkamp et al., Activated protein C resistance shows an association with pregnancy-inducedhypertension, HUM REPR, 14(12), 1999, pp. 3112-3115
Authors:
Serke, S
Riess, H
Oettle, H
Huhn, D
Citation: S. Serke et al., Elevated reticulocyte count - a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report, BR J CANC, 79(9-10), 1999, pp. 1519-1521
Authors:
Horstkotte, D
Riess, H
Citation: D. Horstkotte et H. Riess, Thromboembolic complications following heart valve replacement: The role of patient-related coagulability, J HEART V D, 7(6), 1998, pp. 598-600
Authors:
Riess, H
Swedenborg, J
Citation: H. Riess et J. Swedenborg, The mechanisms of action of alpha- and beta-isoforms of antithrombin - Discussion, BL COAG FIB, 9, 1998, pp. S10-S10
Authors:
Harenberg, J
Schinzel, H
Brockhaus, W
Riess, H
Lechner, K
Matthias, FR
Wieding, J
Marx, G
Weilemann, LS
Citation: J. Harenberg et al., Antithrombin substitution therapy - Discussion, BL COAG FIB, 9, 1998, pp. S21-S22
Authors:
Riess, H
Citation: H. Riess, Antithrombin: Mechanism of action and clinical usage - Proceedings of a symposium, Frankfurt, Germany, 27 February 1998 - Conclusion, BL COAG FIB, 9, 1998, pp. S23-S24
Authors:
Riewald, M
Riess, H
Citation: M. Riewald et H. Riess, Treatment options for clinically recognized disseminated intravascular coagulation, SEM THROMB, 24(1), 1998, pp. 53-59